Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
Navigating Presbyopia Conversations with Patients in Practice
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Global glaucoma disability rates decline despite rising case burden
  • Glaucoma

Global glaucoma disability rates decline despite rising case burden

Optometry 360

Key Takeaways

  1. Global glaucoma AS-DALY rates fell 39% from 1990 to 2023 despite a 52% increase in absolute DALYs.
  2. Burden declined more rapidly in males and remained highest in low-SDI countries.
  3. AS-DALY rates are projected to decrease by another 27.8% by 2050.

Age-standardized disability from glaucoma has fallen worldwide over the past three decades and is expected to continue declining through 2050, according to a new analysis, even as population aging increases the overall number of people affected by glaucoma-related disability.

Researchers analyzed glaucoma-related age-standardized disability-adjusted life-year (AS-DALY) rates across 204 countries and territories.

In 2023, the global AS-DALY rate for glaucoma was 7.46 per 100,000, down 39% from 1990, even as the total number of DALYs increased by 52%. The decline was greater in males than females, with the largest improvement occurring between 2000 and 2015, when 41% of the overall reduction was achieved.

The analysis found substantial differences by socio-demographic Index (SDI), with high- and middle-SDI countries reaching near-minimum burden by 2000 and 2010, respectively, while low-SDI countries continued to experience persistently higher rates with partial rebounds.

The analysis projects that global glaucoma AS-DALY rates will continue declining through 2050 at an average annual rate of 1.2%, for an estimated additional reduction of 27.8% without a rebound.

Reference

Li Y, Fang H, Yu Q, et al. Global, regional, and national burden of glaucoma, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023. Graefes Arch Clin Exp Ophthalmol. 2026;doi: 10.1007/s00417-026-07369-z. Epub ahead of print. PMID: 42461304.

Share

Related Content

  • Glaucoma

Large wearable study examines physical activity and sleep in adults with glaucoma

  • Glaucoma

Optometrists expand role in glaucoma care worldwide, but barriers remain

  • Glaucoma

Adults with ASD show higher rates of glaucoma, cataract, and other eye conditions

  • Glaucoma

Cognitive function and comorbidity linked to different glaucoma medication adherence barriers

  • Glaucoma

AOA 2026: Surgical and technological advances to improve quality of life and reduce drop burden in glaucoma

  • Glaucoma

Ocular surface health may play a key role in glaucoma treatment adherence

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon